MAPT and Alzheimer disease: Using quantitative brain proteomics, Wojtas et al. [191] showed that cerebrovascular-targeted proteins were correlated with amyloid plaques, cerebrovascular amyloid angiopathy, and/or tau pathology in progressive supranuclear palsy (PSP) and AD when compared to controls.